|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 14-04-24 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 14-04-22 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 2023-09-30 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 2017-03-31 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2014-12-31 | |
Haruhisa Inada
BRD | Director/Board Member | - | 2014-04-29 |
Shingo Torii
BRD | Director/Board Member | 73 | 2014-04-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.14% | -2.37% | -14.22% | -33.10% | 230B | ||
| -0.95% | +0.78% | -43.07% | -56.43% | 40.26B | ||
| -2.50% | -1.68% | -42.87% | -54.86% | 20.19B | ||
| -2.02% | -1.40% | -46.44% | -68.88% | 15.48B | ||
| +0.04% | +3.85% | +8.06% | +39.87% | 10.53B | ||
| -1.47% | -1.26% | -45.78% | -72.00% | 8.4B | ||
| +0.47% | +1.46% | +9.28% | -46.64% | 8.12B | ||
| -5.31% | -0.91% | -41.52% | -66.99% | 6.42B | ||
| -1.25% | -1.43% | -32.36% | -55.96% | 5B | ||
| Average | -1.57% | -1.01% | -27.66% | -46.11% | 38.29B | |
| Weighted average by Cap. | -1.25% | -1.32% | -21.02% | -38.71% |
- Stock Market
- Stocks
- Stock
- Stock
Select your edition
All financial news and data tailored to specific country editions
















